A Agilent Technologies Inc.

Agilent Announces Cash Dividend of 23.6 Cents per Share

SANTA CLARA, Calif.--(BUSINESS WIRE)--

Agilent Technologies, Inc. (NYSE: A) today announced a quarterly dividend of 23.6 cents per share of common stock will be paid on Oct. 23, 2024, to all shareholders of record as of the close of business on Oct. 1, 2024.

The timing and amounts of future dividends are subject to determination and approval by Agilent’s board of directors.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.83 billion in fiscal 2023 and employs approximately 18,000 people worldwide. Information about Agilent is available at . To receive the latest Agilent news, subscribe to the . Follow Agilent on and .

Forward-Looking Statements

This news release contains forward-looking statements as defined in the Securities Exchange Act of 1934 and is subject to the safe harbors created therein. The forward-looking statements contained herein include, but are not limited to, information regarding the company’s dividend program and future payment obligations. These forward-looking statements involve risks and uncertainties that could cause Agilent’s results to differ materially from management’s current expectations. Such risks and uncertainties are detailed in Agilent’s filings with the Securities and Exchange Commission, including our quarterly report on Form 10-Q for the quarter ended July 31, 2024. Forward-looking statements are based on the beliefs and assumptions of Agilent’s management and on currently available information. Agilent undertakes no responsibility to publicly update or revise any forward-looking statement.

EN
18/09/2024

Underlying

AAgilent Technologies Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Agilent Technologies Inc.

 PRESS RELEASE
Free
A Agilent Technol...

Agilent Completes Acquisition of BIOVECTRA

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced the company has completed its acquisition of BIOVECTRA, a Canada-based contract development and manufacturing organization (CDMO) that specializes in biologics, highly potent active pharmaceutical ingredients, and other molecules for targeted therapeutics. This press release features multimedia. View the full release here: (Graphic: Business Wire) All closing conditions are completed, including receipt of regulatory approvals. BIOVECTRA is now part of Agilent’s Diagnostics and Genomics Group. “We are de...

September 20, 2024 1 EN
 PRESS RELEASE
Free
A Agilent Technol...

Agilent Announces Cash Dividend of 23.6 Cents per Share

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies, Inc. (NYSE: A) today announced a quarterly dividend of 23.6 cents per share of common stock will be paid on Oct. 23, 2024, to all shareholders of record as of the close of business on Oct. 1, 2024. The timing and amounts of future dividends are subject to determination and approval by Agilent’s board of directors. About Agilent Technologies Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life...

September 18, 2024 1 EN
 PRESS RELEASE
Free
A Agilent Technol...

Agilent Unveils Biopharma CDx Services Lab to Accelerate Precision Med...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- , (NYSE: A) today announced the launch of its in Carpinteria, California, following receipt of California State clinical laboratory license and Clinical Laboratory Improvement Amendments (CLIA) certificate of compliance. These credentials signify that the lab operates in accordance with CLIA regulations, which are federal standards applicable to all U.S. facilities testing human specimens for health assessment, diagnosis, prevention, or treatment of diseases. The CLIA certificate of compliance ensures high standards for accuracy and reliability in labor...

September 9, 2024 1 EN
EUR 160.76
A Agilent Technol...

Moody's Ratings assigns Baa1 rating to Agilent's unsecured notes

Moody's Ratings (Moody's) assigned a Baa1 rating to Agilent Technologies, Inc.'s ("Agilent") new senior unsecured notes. There is no change to the company's existing Baa1 senior unsecured rating and Prime-2 commercial paper rating. The rating outlook is stable. We expect that Agilent will use proc...

A AGILENT TECHNOLOGIES INC.
09/04/24 September 4, 2024 1 EN
 PRESS RELEASE
Free
A Agilent Technol...

Agilent Reports Third-Quarter Fiscal Year 2024 Financial Results

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.58 billion for the third quarter ended July 31, 2024, a decline of 5.6% reported and 4.4% core(1) compared to the third quarter of 2023. Third-quarter GAAP net income was $282 million, or $0.97 per share. This compares with $111 million, or $0.38 per share, in the third quarter of fiscal year 2023. Non-GAAP(2) net income was $385 million, or $1.32 per share during the quarter, compared with $422 million or $1.43 per share during the third quarter a year ago. “The Agilent team executed we...

August 21, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch